advanz pharma uk and ireland limited
advanz pharma uk and ireland limited Company Information
Company Number
09793586
Next Accounts
Sep 2025
Shareholders
mercury pharma group limited
Group Structure
View All
Industry
Wholesale of pharmaceutical goods
Registered Address
dashwood house, 69 old broad street, london, EC2M 1QS
Website
www.interceptpharma.comadvanz pharma uk and ireland limited Estimated Valuation
Pomanda estimates the enterprise value of ADVANZ PHARMA UK AND IRELAND LIMITED at £20.4m based on a Turnover of £14.1m and 1.44x industry multiple (adjusted for size and gross margin).
advanz pharma uk and ireland limited Estimated Valuation
Pomanda estimates the enterprise value of ADVANZ PHARMA UK AND IRELAND LIMITED at £6.5m based on an EBITDA of £448.3k and a 14.57x industry multiple (adjusted for size and gross margin).
advanz pharma uk and ireland limited Estimated Valuation
Pomanda estimates the enterprise value of ADVANZ PHARMA UK AND IRELAND LIMITED at £9.8m based on Net Assets of £5.1m and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Advanz Pharma Uk And Ireland Limited Overview
Advanz Pharma Uk And Ireland Limited is a live company located in london, EC2M 1QS with a Companies House number of 09793586. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in September 2015, it's largest shareholder is mercury pharma group limited with a 100% stake. Advanz Pharma Uk And Ireland Limited is a established, mid sized company, Pomanda has estimated its turnover at £14.1m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Advanz Pharma Uk And Ireland Limited Health Check
Pomanda's financial health check has awarded Advanz Pharma Uk And Ireland Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 7 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
7 Weak
Size
annual sales of £14.1m, make it smaller than the average company (£24.4m)
£14.1m - Advanz Pharma Uk And Ireland Limited
£24.4m - Industry AVG
Growth
3 year (CAGR) sales growth of 4%, show it is growing at a similar rate (5.3%)
4% - Advanz Pharma Uk And Ireland Limited
5.3% - Industry AVG
Production
with a gross margin of 97.1%, this company has a lower cost of product (29.5%)
97.1% - Advanz Pharma Uk And Ireland Limited
29.5% - Industry AVG
Profitability
an operating margin of 3.2% make it less profitable than the average company (4.1%)
3.2% - Advanz Pharma Uk And Ireland Limited
4.1% - Industry AVG
Employees
with 13 employees, this is below the industry average (36)
13 - Advanz Pharma Uk And Ireland Limited
36 - Industry AVG
Pay Structure
on an average salary of £81.1k, the company has an equivalent pay structure (£81.1k)
- Advanz Pharma Uk And Ireland Limited
£81.1k - Industry AVG
Efficiency
resulting in sales per employee of £1.1m, this is more efficient (£654.7k)
£1.1m - Advanz Pharma Uk And Ireland Limited
£654.7k - Industry AVG
Debtor Days
it gets paid by customers after 127 days, this is later than average (57 days)
127 days - Advanz Pharma Uk And Ireland Limited
57 days - Industry AVG
Creditor Days
its suppliers are paid after 1227 days, this is slower than average (30 days)
1227 days - Advanz Pharma Uk And Ireland Limited
30 days - Industry AVG
Stock Days
it holds stock equivalent to 286 days, this is more than average (64 days)
286 days - Advanz Pharma Uk And Ireland Limited
64 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 3 weeks, this is less cash available to meet short term requirements (11 weeks)
3 weeks - Advanz Pharma Uk And Ireland Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 85.7%, this is a higher level of debt than the average (54.3%)
85.7% - Advanz Pharma Uk And Ireland Limited
54.3% - Industry AVG
ADVANZ PHARMA UK AND IRELAND LIMITED financials
Advanz Pharma Uk And Ireland Limited's latest turnover from December 2023 is £14.1 million and the company has net assets of £5.1 million. According to their latest financial statements, Advanz Pharma Uk And Ireland Limited has 13 employees and maintains cash reserves of £1.8 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | 14,121,158 | 12,207,278 | 11,866,749 | 12,446,300 | 8,968,950 | 5,322,691 | 555,827 | |
| Other Income Or Grants | ||||||||
| Cost Of Sales | 410,708 | 5,373,753 | 10,976,816 | 12,072,218 | 8,789,510 | 5,219,313 | 520,647 | |
| Gross Profit | 13,710,450 | 6,833,525 | 889,933 | 374,082 | 179,440 | 103,378 | 35,180 | |
| Admin Expenses | 13,262,133 | 5,988,689 | 416,233 | -123,769 | -179,316 | -109,528 | 4,589,317 | 584,118 |
| Operating Profit | 448,317 | 844,836 | 473,700 | 497,851 | 358,756 | 212,906 | -4,554,137 | -584,118 |
| Interest Payable | ||||||||
| Interest Receivable | ||||||||
| Pre-Tax Profit | 448,317 | 844,836 | 473,700 | 497,851 | 358,756 | 212,906 | -4,554,137 | -584,118 |
| Tax | -29,417 | |||||||
| Profit After Tax | 418,900 | 844,836 | 473,700 | 497,851 | 358,756 | 212,906 | -4,554,137 | -584,118 |
| Dividends Paid | ||||||||
| Retained Profit | 418,900 | 844,836 | 473,700 | 497,851 | 358,756 | 212,906 | -4,554,137 | -584,118 |
| Employee Costs | 1,520,016 | 2,029,204 | 1,821,483 | 1,606,316 | 2,952,725 | 410,824 | ||
| Number Of Employees | 13 | 14 | 14 | 15 | 14 | |||
| EBITDA* | 448,317 | 844,836 | 473,700 | 497,851 | 358,756 | 212,906 | -4,554,137 | -584,118 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | ||||||||
| Intangible Assets | ||||||||
| Investments & Other | ||||||||
| Debtors (Due After 1 year) | ||||||||
| Total Fixed Assets | ||||||||
| Stock & work in progress | 322,863 | 153,176 | ||||||
| Trade Debtors | 4,933,695 | 5,092,718 | 4,529,021 | 3,815,464 | 2,771,829 | 2,476,623 | 574,043 | |
| Group Debtors | 28,482,167 | 25,379,012 | 10,455,427 | 9,290,086 | 8,000,632 | 2,999,632 | 44,686 | |
| Misc Debtors | 214,183 | 154,667 | 44,493 | 1,309 | ||||
| Cash | 1,830,868 | 6,847,604 | 1,561,547 | 956,380 | 741,739 | 1,274,420 | 1,017,588 | 199,841 |
| misc current assets | ||||||||
| total current assets | 35,783,776 | 37,627,177 | 16,545,995 | 14,061,930 | 11,514,200 | 6,750,675 | 1,680,810 | 201,150 |
| total assets | 35,783,776 | 37,627,177 | 16,545,995 | 14,061,930 | 11,514,200 | 6,750,675 | 1,680,810 | 201,150 |
| Bank overdraft | ||||||||
| Bank loan | ||||||||
| Trade Creditors | 1,381,456 | 1,747,896 | 141,430 | 228,652 | 120,686 | 150,663 | 15,220 | |
| Group/Directors Accounts | 25,276,781 | 27,599,443 | 10,816,107 | 7,574,115 | 7,652,164 | 5,274,465 | 1,372,301 | 226,159 |
| other short term finances | ||||||||
| hp & lease commitments | ||||||||
| other current liabilities | 2,110,853 | 2,440,495 | 1,739,637 | 3,229,682 | 1,748,457 | 766,715 | 456,816 | 245,724 |
| total current liabilities | 28,769,090 | 31,787,834 | 12,697,174 | 11,032,449 | 9,521,307 | 6,191,843 | 1,844,337 | 471,883 |
| loans | ||||||||
| hp & lease commitments | ||||||||
| Accruals and Deferred Income | ||||||||
| other liabilities | ||||||||
| provisions | 1,902,129 | 1,145,686 | ||||||
| total long term liabilities | 1,902,129 | 1,145,686 | ||||||
| total liabilities | 30,671,219 | 32,933,520 | 12,697,174 | 11,032,449 | 9,521,307 | 6,191,843 | 1,844,337 | 471,883 |
| net assets | 5,112,557 | 4,693,657 | 3,848,821 | 3,029,481 | 1,992,893 | 558,832 | -163,527 | -270,733 |
| total shareholders funds | 5,112,557 | 4,693,657 | 3,848,821 | 3,029,481 | 1,992,893 | 558,832 | -163,527 | -270,733 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | 448,317 | 844,836 | 473,700 | 497,851 | 358,756 | 212,906 | -4,554,137 | -584,118 |
| Depreciation | ||||||||
| Amortisation | ||||||||
| Tax | -29,417 | |||||||
| Stock | 169,687 | 153,176 | ||||||
| Debtors | 3,003,648 | 15,641,949 | 1,878,898 | 2,333,089 | 5,296,206 | 4,813,033 | 661,913 | 1,309 |
| Creditors | -366,440 | 1,606,466 | -87,222 | 107,966 | -29,977 | 135,443 | 15,220 | |
| Accruals and Deferred Income | -329,642 | 700,858 | -1,490,045 | 1,481,225 | 981,742 | 309,899 | 211,092 | 245,724 |
| Deferred Taxes & Provisions | 756,443 | 1,145,686 | ||||||
| Cash flow from operations | -2,694,074 | -11,497,279 | -2,982,465 | -246,047 | -3,985,685 | -4,154,785 | -4,989,738 | -339,703 |
| Investing Activities | ||||||||
| capital expenditure | ||||||||
| Change in Investments | ||||||||
| cash flow from investments | ||||||||
| Financing Activities | ||||||||
| Bank loans | ||||||||
| Group/Directors Accounts | -2,322,662 | 16,783,336 | 3,241,992 | -78,049 | 2,377,699 | 3,902,164 | 1,146,142 | 226,159 |
| Other Short Term Loans | ||||||||
| Long term loans | ||||||||
| Hire Purchase and Lease Commitments | ||||||||
| other long term liabilities | ||||||||
| share issue | ||||||||
| interest | ||||||||
| cash flow from financing | -2,322,662 | 16,783,336 | 3,587,632 | 460,688 | 3,453,004 | 4,411,617 | 5,807,485 | 539,544 |
| cash and cash equivalents | ||||||||
| cash | -5,016,736 | 5,286,057 | 605,167 | 214,641 | -532,681 | 256,832 | 817,747 | 199,841 |
| overdraft | ||||||||
| change in cash | -5,016,736 | 5,286,057 | 605,167 | 214,641 | -532,681 | 256,832 | 817,747 | 199,841 |
advanz pharma uk and ireland limited Credit Report and Business Information
Advanz Pharma Uk And Ireland Limited Competitor Analysis
Perform a competitor analysis for advanz pharma uk and ireland limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mid companies, companies in EC2M area or any other competitors across 12 key performance metrics.
advanz pharma uk and ireland limited Ownership
ADVANZ PHARMA UK AND IRELAND LIMITED group structure
Advanz Pharma Uk And Ireland Limited has no subsidiary companies.
Ultimate parent company
ADVANZ PHARMA HOLDO LTD
#0148955
2 parents
ADVANZ PHARMA UK AND IRELAND LIMITED
09793586
advanz pharma uk and ireland limited directors
Advanz Pharma Uk And Ireland Limited currently has 3 directors. The longest serving directors include Mr Simon Tucker (Jul 2022) and Mr Nicholas Ettery (Feb 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Simon Tucker | United Kingdom | 50 years | Jul 2022 | - | Director |
| Mr Nicholas Ettery | United Kingdom | 52 years | Feb 2024 | - | Director |
| Mr Melvin Ferry | United Kingdom | 42 years | Feb 2025 | - | Director |
P&L
December 2023turnover
14.1m
+16%
operating profit
448.3k
-47%
gross margin
97.1%
+73.44%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
5.1m
+0.09%
total assets
35.8m
-0.05%
cash
1.8m
-0.73%
net assets
Total assets minus all liabilities
Similar Companies
advanz pharma uk and ireland limited company details
company number
09793586
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
September 2015
age
10
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
intercept pharma uk & ireland ltd (August 2022)
accountant
-
auditor
AZETS AUDIT SERVICES LIMITED
address
dashwood house, 69 old broad street, london, EC2M 1QS
Bank
-
Legal Advisor
-
advanz pharma uk and ireland limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to advanz pharma uk and ireland limited.
advanz pharma uk and ireland limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ADVANZ PHARMA UK AND IRELAND LIMITED. This can take several minutes, an email will notify you when this has completed.
advanz pharma uk and ireland limited Companies House Filings - See Documents
| date | description | view/download |
|---|
